Yo-Ting Tsai

Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27

Han‐Shui Hsu, Jiun‐Han Lin, Wen‐Chien Huang et al. · Cancer · 2010 · 144 citations

Medicine, Oncology, Pharmacology +15

Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma

Arun Rajan, Christopher R. Heery, Anish Thomas et al. · Journal for ImmunoTherapy of Cancer · 2019 · 138 citations · Full text

Life Sciences, Immunology, Oncology +17

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

Marijo Bilušić, Sheri McMahon, Ravi A. Madan et al. · Journal for ImmunoTherapy of Cancer · 2021 · 61 citations · Full text

Life Sciences, Immunology, Oncology +17

Undecylprodigiosin selectively induces apoptosis in human breast carcinoma cells independent of p53

Tsing-Fen Ho, Chieh-Ju Ma, Chien‐Hsing Lu et al. · Toxicology and Applied Pharmacology · 2007 · 55 citations

Life Sciences, Cancer Biology, Oncology +12

A Randomized Phase II Trial of mFOLFOX6 + Bevacizumab Alone or with AdCEA Vaccine + Avelumab Immunotherapy for Untreated Metastatic Colorectal Cancer

Jason M. Redman, Yo-Ting Tsai, Benjamin A. Weinberg et al. · The Oncologist · 2022 · 50 citations · Full text

Medicine, Immunology, Oncology +12